BRIEF published on 11/05/2024 at 13:15, 1 year 10 months ago BlackRock Inc. réduit sa participation dans Arkema Droits De Vote Franchissement De Seuil Actions BlackRock ARKEMA
BRIEF published on 11/05/2024 at 13:15, 1 year 10 months ago BlackRock Inc. reduces its stake in Arkema Voting Rights Actions BlackRock Threshold Crossing ARKEMA
PRESS RELEASE published on 11/05/2024 at 13:10, 1 year 10 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour Arkema, le 31 octobre 2024 Capital Déclaration Franchissement De Seuil BlackRock Inc. ARKEMA
BRIEF published on 11/04/2024 at 16:01, 1 year 10 months ago BlackRock dépasse le seuil de 5% de participation dans ARKEMA Capital Franchissement De Seuil Participation BlackRock ARKEMA
BRIEF published on 11/04/2024 at 16:01, 1 year 10 months ago BlackRock exceeds 5% stake threshold in ARKEMA Capital Participation BlackRock Threshold Crossing ARKEMA
PRESS RELEASE published on 11/04/2024 at 15:56, 1 year 10 months ago Franchissement de seuil Déclaration de franchissement de seuil de 5% du capital de ARKEMA par BlackRock Inc. pour le compte de clients et fonds, le 30 octobre 2024 Franchissement De Seuil BlackRock Inc. 5% Du Capital ARKEMA 30 Octobre 2024
BRIEF published on 10/08/2024 at 14:45, 1 year 11 months ago Arkema Announces Share Buyback Transactions Share Buyback Financial Disclosure Market Activity Stock Transactions ARKEMA
BRIEF published on 10/08/2024 at 14:45, 1 year 11 months ago Arkema annonce des opérations de rachat d'actions Rachat D'actions Divulgation Financière Transactions Sur Actions ARKEMA Activité Du Marché
PRESS RELEASE published on 10/08/2024 at 14:40, 1 year 11 months ago Inside Information / Other news releases Arkema disclosed trading in own shares in compliance with regulations from 30 September to 04 October 2024 Share Buyback Trading Compliance Regulations ARKEMA
PRESS RELEASE published on 10/08/2024 at 14:40, 1 year 11 months ago Informations privilégiées / Autres communiqués Arkema déclare avoir effectué des transactions sur actions propres conformément à la réglementation en vigueur du 30 septembre au 04 octobre 2024 Transactions Sur Actions Propres Réglementation Achats D'actions Volume Total ARKEMA
Published on 09/11/2026 at 04:00, 5 hours 50 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 25 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 30 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 50 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 30 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 45 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 50 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 50 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 20 minutes ago Availability of the 2026 Interim Financial Report